Cancers | Cancer Immunotherapy Awareness Month
June is designated as “Cancer Immunotherapy Awareness Month”, with various global activities to celebrate in this important month. Immunotherapy is a type of cancer treatment and can be used alone or in combination with chemotherapy and/or other cancer treatments. Taking this opportunity, we would like to extend our appreciation to all the researchers who have contributed to the fight against cancer. In particular, we would like to share some of the high-quality and innovative research findings in the field of cancer immunotherapy, published in Cancers (ISSN: 2072-6694).
We hope this announcement will provide useful information for this field.
“Recent Advances and Challenges in Cancer Immunotherapy”
by Chelsea Peterson, Nathan Denlinger and Yiping Yang
Cancers 2022, 14(16), 3972; https://doi.org/10.3390/cancers14163972
Available online: https://www.mdpi.com/2072-6694/14/16/3972
“Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404
“The New Era of Immunotherapy in Gastric Cancer”
by Shogo Takei, Akihito Kawazoe and Kohei Shitara
Cancers 2022, 14(4), 1054; https://doi.org/10.3390/cancers14041054
Available online: https://www.mdpi.com/2072-6694/14/4/1054
“BCG in Bladder Cancer Immunotherapy”
by Song Jiang and Gil Redelman-Sidi
Cancers 2022, 14(13), 3073; https://doi.org/10.3390/cancers14133073
Available online: https://www.mdpi.com/2072-6694/14/13/3073
“Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy”
by Jang Hyun Park and Heung Kyu Lee
Cancers 2022, 14(5), 1176; https://doi.org/10.3390/cancers14051176
Available online: https://www.mdpi.com/2072-6694/14/5/1176
“CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy”
by Rosanna Mezzapelle, Manuela Leo, Francesca Caprioglio, Liam S. Colley, Andrea Lamarca, Lina Sabatino, Vittorio Colantuoni, Massimo P. Crippa and Marco E. Bianchi
Cancers 2022, 14(9), 2314; https://doi.org/10.3390/cancers14092314
Available online: https://www.mdpi.com/2072-6694/14/9/2314
“Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives”
by Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Lucia Del Mastro, Martino Introna, Carlo Tondini, Armando Santoro and Alberto Zambelli
Cancers 2022, 14(9), 2136; https://doi.org/10.3390/cancers14092136
Available online: https://www.mdpi.com/2072-6694/14/9/2136
“Electroporation and Immunotherapy—Unleashing the Abscopal Effect”
by Tobias Freyberg Justesen, Adile Orhan, Hans Raskov, Christian Nolsoe and Ismail Gögenur
Cancers 2022, 14(12), 2876; https://doi.org/10.3390/cancers14122876
Available online: https://www.mdpi.com/2072-6694/14/12/2876
“Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer”
by Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz and Carlos Camps Herrero
Cancers 2022, 14(2), 307; https://doi.org/10.3390/cancers14020307
Available online: https://www.mdpi.com/2072-6694/14/2/307
“Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy”
by Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka et al.
Cancers 2022, 14(4), 883; https://doi.org/10.3390/cancers14040883
Available online: https://www.mdpi.com/2072-6694/14/4/883
“How Did Conventional Nanoparticle-Mediated Photothermal Therapy Become “Hot” in Combination with Cancer Immunotherapy?”
by Wan Su Yun, Ji-Ho Park, Dong-Kwon Lim, Cheol-Hee Ahn, In-Cheol Sun and Kwangmeyung Kim
Cancers 2022, 14(8), 2044; https://doi.org/10.3390/cancers14082044
Available online: https://www.mdpi.com/2072-6694/14/8/2044
“Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes”
by Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco et al.
Cancers 2022, 14(10), 2429; https://doi.org/10.3390/cancers14102429
Available online: https://www.mdpi.com/2072-6694/14/10/2429
“Immunotherapy in Melanoma: Recent Advances and Future Directions”
by Andrew Knight, Lilit Karapetyan and John M. Kirkwood
Cancers 2023, 15(4), 1106; https://doi.org/10.3390/cancers15041106
Available online: https://www.mdpi.com/2072-6694/15/4/1106
“The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy”
by Yanlin Yu
Cancers 2023, 15(8), 2323; https://doi.org/10.3390/cancers15082323
Available online: https://www.mdpi.com/2072-6694/15/8/2323
“Chemo-Immunotherapy: A New Trend in Cancer Treatment”
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Alejandra Martínez-Pérez, Juan P. Rodrigo, Juana M. García-Pedrero and Segundo Gonzalez
Cancers 2023, 15(11), 2912; https://doi.org/10.3390/cancers15112912
Available online: https://www.mdpi.com/2072-6694/15/11/2912
“Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome”
by Liying Li, Fan Zhang, Zhenyu Liu and Zhimin Fan
Cancers 2023, 15(1), 321; https://doi.org/10.3390/cancers15010321
Available online: https://www.mdpi.com/2072-6694/15/1/321
“FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects”
by Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Malik E. Juweid, Kamal Al-Rabi, Mohammad Ma’koseh, Hikmat Abdel-Razeq and Asem Mansour
Cancers 2023, 15(4), 1063; https://doi.org/10.3390/cancers15041063
Available online: https://www.mdpi.com/2072-6694/15/4/1063
“Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies”
by Justin H. Lo, Rajiv Agarwal, Laura W. Goff and Thatcher R. Heumann
Cancers 2023, 15(13), 3312; https://doi.org/10.3390/cancers15133312
Available online: https://www.mdpi.com/2072-6694/15/13/3312
“Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer”
by Hongzhong Jin, Shichong Liao, Feng Yao, Juanjuan Li, Zhiliang Xu, Kailiang Zhao, Ximing Xu and Shengrong Sun
Cancers 2023, 15(5), 1532; https://doi.org/10.3390/cancers15051532
Available online: https://www.mdpi.com/2072-6694/15/5/1532
“Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy”
by Vinith Johnson, Sunil Vasu, Uday S. Kumar and Manoj Kumar
Cancers 2023, 15(10), 2838; https://doi.org/10.3390/cancers15102838
Available online: https://www.mdpi.com/2072-6694/15/10/2838
“Decoding the Complexity of Immune–Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy”
by Kaitlyn Maffuid and Yanguang Cao
Cancers 2023, 15(16), 4188; https://doi.org/10.3390/cancers15164188
Available online: https://www.mdpi.com/2072-6694/15/16/4188
“From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy”
by Peter Vaupel, Helmut Piazena, Markus Notter, Andreas R. Thomsen, Anca-L. Grosu, Felix Scholkmann, Alan Graham Pockley and Gabriele Multhoff
Cancers 2023, 15(5), 1394; https://doi.org/10.3390/cancers15051394
Available online: https://www.mdpi.com/2072-6694/15/5/1394
“The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer”
by Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli and Ugo De Giorgi
Cancers 2023, 15(5), 1597; https://doi.org/10.3390/cancers15051597
Available online: https://www.mdpi.com/2072-6694/15/5/1597
“Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer”
by Clelia Madeddu, Silvia Busquets, Clelia Donisi, Eleonora Lai, Andrea Pretta, Francisco Javier López-Soriano, Josep Maria Argilés, Mario Scartozzi and Antonio Macciò
Cancers 2023, 15(4), 1076; https://doi.org/10.3390/cancers15041076
Available online: https://www.mdpi.com/2072-6694/15/4/1076